Bellevue Group’s GoHealth GOCO Stock Holding History

Bellevue Group’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,495	Closed	-$4.61M	–	226
2020 Q4	$4.61M	Buy	22,495 +1,517	+7%	+$282K	0.05%	126
2020 Q3	$4.1M	Buy	+20,978	New	+$5.05M	0.06%	128

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bellevue Group's GOCO Position: Q1 2021 in Review

Bellevue Group sold out of GoHealth (GOCO) in Q1 2021, closing a stake of 22,495 shares — an estimated $4.61M sold.

Bellevue Group first reported a position in GOCO in Q3 2020 and held it in 2 quarters. The position peaked at $4.61M in Q4 2020. 109 funds tracked by Wall St. Rank hold GOCO as of Q1 2021.

Bellevue Group reported no remaining GoHealth position as of Q1 2021 after selling out during the quarter.
Bellevue Group sold 22,495 GoHealth shares in Q1 2021, an estimated $4.61M.
Bellevue Group first reported a position in GoHealth in Q3 2020 and held it in 2 quarters.
Bellevue Group's GoHealth position peaked at $4.61M in Q4 2020.
109 funds tracked by Wall St. Rank held GoHealth as of Q1 2021.

Based on Bellevue Group's 13F filing for Q1 2021, filed 12 May 2021.